Gyre Therapeutics Inc expected to post earnings of 3 cents a share - Earnings Preview

Gyre Therapeutics

05/05/2025 12:17

Gyre Therapeutics Inc GYRE.OQ GYRE.O is expected to report resultson May 7 (estimated) for the period ending March 31 2025

The San Diego California-based  company is expected to report revenue of $28.4 million, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Gyre Therapeutics Inc is for earnings of 3 cents per share.

The one available analyst rating on the shares is "buy".

The average consensus recommendation for the biotechnology & medical research peer group is also "Buy".​

Wall Street's median 12-month price target for Gyre Therapeutics Inc is $20.00​, above​ its last closing price of $9.26. ​​​

This summary was machine generated May 5 at 11:17 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)